Order Article Reprints

Hsu P-C, Wu B-C, Wang C-C, Chiu L-C, Chang C-H, Liu P-C, Wu C-E, Kuo SC-H, Ju J-S, Huang AC-C, et al. A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Vaccines. 2024; 12(5):474. https://doi.org/10.3390/vaccines12050474

Hsu, Ping-Chih, Bing-Chen Wu, Chin-Chou Wang, Li-Chung Chiu, Chiung-Hsin Chang, Ping-Chi Liu, Chiao-En Wu, Scott Chih-Hsi Kuo, Jia-Shiuan Ju, Allen Chung-Cheng Huang, and et al. 2024. "A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer" Vaccines 12, no. 5: 474. https://doi.org/10.3390/vaccines12050474

Hsu, P.-C., Wu, B.-C., Wang, C.-C., Chiu, L.-C., Chang, C.-H., Liu, P.-C., Wu, C.-E., Kuo, S. C.-H., Ju, J.-S., Huang, A. C.-C., Lin, Y.-C., Yang, C.-T., & Ko, H.-W. (2024). A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Vaccines, 12(5), 474. https://doi.org/10.3390/vaccines12050474